The calcium channel antagonist omega-conotoxin inhibits secretion from peptidergic nerve terminals

Biochem Biophys Res Commun. 1988 Oct 14;156(1):255-62. doi: 10.1016/s0006-291x(88)80833-7.

Abstract

The binding of omega-conotoxin to isolated rat neurohypophysial nerve terminals, its effect on the depolarization-induced increase of cytoplasmic Ca2+ and on the potassium and electrically-induced release of vasopressin (AVP) have been studied. The results show that isolated neurosecretory nerve endings have calcium channels with a high affinity for omega-CgTx and that this toxin inhibits neurohormone release at very low concentration (IC50 = 0. 1nM). Although secretion of vasopressin is inhibited to a great extent by the toxin it is shown that a small but significant amount of the depolarization-induced AVP release is insensitive to omega-CgTx and to the dihydropyridine molecule nicardipine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arginine Vasopressin / metabolism*
  • Calcium Channel Blockers / pharmacology*
  • Cell Membrane / physiology
  • Dihydropyridines / pharmacology
  • Electric Stimulation
  • In Vitro Techniques
  • Kinetics
  • Male
  • Mollusk Venoms / metabolism
  • Mollusk Venoms / pharmacology*
  • Nerve Endings / drug effects
  • Nerve Endings / physiology*
  • Nicardipine / pharmacology
  • Pituitary Gland, Posterior / drug effects
  • Pituitary Gland, Posterior / metabolism
  • Pituitary Gland, Posterior / physiology*
  • Potassium / pharmacology
  • Rats
  • Reference Values
  • Verapamil / analogs & derivatives
  • Verapamil / pharmacology
  • omega-Conotoxin GVIA

Substances

  • Calcium Channel Blockers
  • Dihydropyridines
  • Mollusk Venoms
  • Arginine Vasopressin
  • 1,4-dihydropyridine
  • omega-Conotoxin GVIA
  • 4-desmethoxyverapamil
  • Verapamil
  • Nicardipine
  • Potassium